Monday, November 06, 2006

Abbott To Buy Kos

Abbott Laboratories (ABT) agreed to acquire the cholesterol drugmaker Kos Pharmaceuticals Inc. (KOSP) for $3.7 billion. Shares of Kos leaped $26.97 to close at $77.06 while Abbott stock eased 17 cents to close at $47.47.

0 Comments:

Post a Comment

<< Home